BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CTMSS - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://clinicaltmssociety.org
X-WR-CALDESC:Events for CTMSS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260707T200000
DTEND;TZID=UTC:20260707T210000
DTSTAMP:20260608T081844
CREATED:20260601T160340Z
LAST-MODIFIED:20260601T160413Z
UID:4277-1783454400-1783458000@clinicaltmssociety.org
SUMMARY:Clinical Outcomes Comparing MST and ECT in Patients with Depression
DESCRIPTION:> >Register Now <<\nSpeaker: Daniel M. Blumberger\, MD\, MSc\, FRCPC\, FCTMSS\nThis presentation will present data from a large confirmatory efficacy trial of Magnetic Seizure Therapy in unipolar Depression and a smaller trial in patients with Bipolar Depression.\nThis treatment utilizes transcranial magnetic stimulation to induce a brief seizure with the hope of inducing similar clinical benefit without cognitive adverse effects of ECT. \nKey learning objectives include:\n\nReview the background and rationale for studying MST and ECT in the treatment of depression.\nUnderstand the methodology and design of the CREST and CORRECT-BD trials.\nEvaluate the efficacy\, safety\, tolerability\, and clinical implications of MST as a potential treatment for TRD.\n\nOne CME credit is available.  CE Language \nTake advantage of our live Q&A session at the conclusion of the webinar. \n*Registered attendees will receive access to the on-demand video recording by Friday\, July 10\, 2026. You will receive an email notification with instructions on accessing the video. You may register for the on-demand webinar any time after the live webinar. \nWhen: \nUSA - July 7\, 2026 at 8:00pm ET | 5:00pm PT\nUK- July 8\, 2026 at 1:00am BST\nAustralia- July 8\, 2026 at 10:00am AEST \nCost: \nMember: $25\nTrainee Member: FREE\nNon-Member: $50 \n> >Register Now <<\nAbout the Speaker \n \nDaniel M. Blumberger\, MD\, MSc\, FRCPC\, FCTMSS\n \nDr. Blumberger is a Senior Scientist in the Campbell Family Mental Health Research Institute at Centre for Addiction and Mental Health and a subspecialist in geriatric psychiatry. He is the Temerty Chair in Therapeutic Brain Intervention and the Scientific Director of the Temerty Centre for Therapeutic Brain Intervention. He is the Chief of the General Adult Psychiatry and Health Systems Division at CAMH and is a Professor in the Department of Psychiatry at the University of Toronto. He is the Provincial Clinical Lead for Neurostimulation Procedure for Ontario Health. \nHis primary area of research focuses on clinical intervention trials of neurostimulation and other novel treatments for depression across the lifespan. \nHe is the principal or co-investigator on multiple clinical trials using different interventional psychiatry modalities including: psilocybin assisted psychotherapy\, IV ketamine\, electroconvulsive therapy (ECT)\, magnetic seizure therapy (MST)\, repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS).
URL:https://clinicaltmssociety.org/event/clinical-outcomes-comparing-mst-and-ect-in-patients-with-depression/
CATEGORIES:Grand Rounds Webinar
END:VEVENT
END:VCALENDAR